This was a cause before it was a company
Auris is honored to have the support of leading global investors, including early backers Mithril, Lux Capital and Highland Capital Partners. We would also like to welcome Coatue Management LLC as the lead of our Series D financing, which totaled $280 million. Additional Series D investors included Partner Fund Management. Auris has raised over 500 million dollars in financing, a record for medical technology start-ups, further validating Auris vision.
Frederic H. Moll, M.D. is the CEO of Auris Health, Inc. Prior to Auris, Dr. Moll co-Founded Hansen Medical and served as the company’s Chief Executive Officer from 2002 - 2010. Previously, Dr. Moll co-founded Intuitive Surgical, Inc., a medical device company, and served as its first Chief Executive Officer and later, its Vice President and Medical Director. Dr. Moll co-founded Origin Medsystems, Inc., a medical device company, which later became an operating company within Guidant Corporation, a medical device company, following its acquisition by Eli Lilly in 1992. Dr. Moll served as Medical Director of Guidant’s Surgical Device Division until November 1995.
Ajay co-founded Mithril in 2012 and leads the firm as its Managing General Partner. He was formerly Managing Director and Senior Investor at Clarium, where he led unlevered growth investments. He co-founded Breakout Labs, has been a recurring guest lecturer on macro investing at Yale, and serves as an external adviser to Oak Ridge National Laboratory and the University of Michigan Risk Science Center. He earned a B.A. from Yale.
Peter is co-founder of Lux Capital and focuses on investments in technology and energy. Peter began his career at Lehman Brothers, where he worked in the firm’s top-ranked Equity Research group. In 2000, he co-founded Lux Capital. In 2003, Peter led the spin-off of Lux Research. As founding CEO, he helped build Lux Research into the leading emerging technology research firm.
Dr. Salehizadeh has over 15 years of healthcare operating and investment experience. Prior to co-founding NaviMed Capital, he was a General Partner at Highland Capital Partners, where he focused on growth stage healthcare investments. Prior to joining Highland Capital Partners in 2003, Dr. Salehizadeh spent several years in a variety of operational roles at Medtronic. Before Medtronic, Dr. Salehizadeh held a variety of senior management roles with HealthCentral, a private equity-backed, digital health company that went public in 1999. Dr. Salehizadeh holds an AB in Molecular Biology from Princeton University, an MD and Master of Science in Health Policy from Columbia University, and an MBA from Harvard Business School. He is also a graduate of the Kauffman Fellows Program.
Bob Kerrey is Managing Director at Allen & Company. He is also a former governor, senator and education leader and serves as Executive Chairman of the Minerva Institute for Research and Scholarship, supporting The Minerva Project, an exceptional liberal arts and sciences education. From 1983 to 1987, Kerry served a single term as Nebraska’s governor, and later represented Nebraska in the U.S. Senate from 1989 to 2001. Kerrey was a candidate for the Democratic presidential nomination in 1992. Before entering politics, he served in the Vietnam War as a Navy SEAL officer and was awarded the Congressional Medal of Honor for heroism in combat.
We are creating a new future.